Safety and Efficacy of Sitaxsentan in the Treatment of Pulmonary Arterial Hypertension - Related Studies

Safety and Efficacy of Sitaxsentan in the Treatment of Pulmonary Arterial Hypertension

This study is ongoing, but not recruiting participants.

Study NCT00034307. Last updated on June 23, 2005. Information provided by ICOS-Texas Biotechnology

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Pulmonary Hypertension

2	Additional conditions recognized in this trial
		Hypertension
		Hypertension, Pulmonary

3	More general conditions related to this trial
		Cardiovascular Diseases
		Lung Diseases
		Respiratory Tract Diseases
		Vascular Diseases

4	Interventions listed in this trial
		sitaxsentan sodium

5	Sponsors listed in this trial
		ICOS-Texas Biotechnology
		ICOS Corporation
		Texas Biotechnology Corporation